What is the current evidence regarding the use of low‑profile flow‑diverter devices for aneurysms of the anterior cerebral artery (ACA), middle cerebral artery (MCA), and basilar tip?

Flow Diverters for ACA, MCA, and Basilar Tip Aneurysms: Evidence Review

Flow diverters can be considered for carefully selected unruptured aneurysms in these locations, but their use remains largely off-label with location-specific risks that must be weighed against alternative treatments.

Key Guideline Framework

The 2023 AHA/ASA guidelines provide critical context: for ruptured saccular aneurysms amenable to primary coiling or clipping, stents or flow diverters should NOT be used to avoid higher risk of complications 1. However, for ruptured wide-neck or fusiform/blister aneurysms not amenable to standard treatment, flow diverters are reasonable 1. For unruptured aneurysms, the 2015 AHA/ASA guidelines note that flow-diverting devices represent "compelling new treatment strategies" but emphasize strict adherence to FDA indications until additional trial data demonstrate incremental improvement 2.

Location-Specific Evidence

Anterior Cerebral Artery (ACA) Aneurysms

Distal ACA aneurysms (A2 and beyond) show promising results with flow diverters:

• Efficacy: Pooled data from 326 patients demonstrates 89% adequate occlusion and 77% complete occlusion at last follow-up 3
• Safety: 97% good functional outcomes (mRS 0-2), only 1% procedure-related morbidity, zero mortality 3
• Complications: In-stent stenosis in 4%, covered branch occlusion in 10% (but symptomatic in only 1.1%, likely due to robust collateral circulation in distal ACA territory) 3
• Retreatment: Only 1% required retreatment 3

For anterior communicating artery (ACom) aneurysms specifically:

• Complete/near-complete occlusion: 78% at mean 12.5-month follow-up 4
• Good outcomes (mRS 0-2): 94.7% 4
• Complication rate: 21%, but mortality only 1% 4
• Technical challenge: Small vessel caliber and bifurcation anatomy make these technically demanding 4

Clinical caveat: Most treated ACA aneurysms were unruptured (93.7-95.7%), small (<10mm), and saccular 3, 5. The evidence base is predominantly retrospective without centralized adjudication.

Middle Cerebral Artery (MCA) Aneurysms

MCA M1 aneurysms present unique challenges with flow diverters:

• Ischemic risk: Postprocedural cerebral ischemia occurred in 25.9% of cases 6
• Rupture status matters critically: Ruptured aneurysms had 26.7% ischemia rate vs. only 2.3% in unruptured (p=0.013), with rupture independently predicting ischemia (OR 15.3) 6
• Efficacy: Complete occlusion achieved in 77.4% at median 13-month follow-up 6
• Predictors of failure: Aneurysm wall enhancement on MRI independently predicts incomplete occlusion (OR 6.6) 6

Important guideline context: The 2015 AHA/ASA guidelines state there "appears to be an advantage to microsurgery in the treatment of most middle cerebral artery aneurysms" 2. The 2023 guidelines note that "ruptured MCA aneurysms, and anterior circulation bifurcation aneurysms in general, are typically considered more favorable for clipping" 1.

Practical algorithm for MCA aneurysms:

1. If ruptured → strongly favor clipping over flow diversion (15-fold higher ischemic risk with FD)
2. If unruptured and surgically accessible → consider clipping first-line
3. If unruptured with high surgical risk (elderly, medical comorbidities, unfavorable anatomy) → flow diversion may be considered
4. Check preoperative MRI for wall enhancement → if present, anticipate higher incomplete occlusion risk

Basilar Tip Aneurysms

Basilar apex aneurysms have the most concerning safety profile with flow diverters:

• Mortality: Procedure-related mortality 15% overall for posterior circulation aneurysms, with significantly higher rates for basilar artery aneurysms 7
• Ischemic complications: 11% ischemic stroke rate, 7% perforator infarction rate 7
• Efficacy: 84% complete occlusion at 6-month follow-up 7
• Rupture status: Giant and ruptured basilar aneurysms have particularly poor outcomes 7

More recent single-center data (2025) shows improved results:

• Complete/near-complete occlusion: 86.7% at mean 12.9-month follow-up 8
• Complications: 13.3% (all transient ischemic symptoms, no permanent deficits) 8
• Excellent outcomes (mRS 0-1): 93.3% 8
• Critical note: 70% were basilar trunk aneurysms, only 30% basilar apex 8

Guideline preference: The 2015 AHA/ASA guidelines explicitly state "there appears to be an advantage...for endovascular repair in the treatment of most basilar apex and vertebrobasilar confluence aneurysms" 2, but this refers to coiling, not flow diversion. The 2012 guidelines note that for basilar apex aneurysms, endovascular treatment (coiling) showed 11% poor outcomes vs. 30% with surgery 9.

Decision algorithm for basilar tip aneurysms:

1. First-line: Attempt primary coiling if anatomy permits
2. If wide-neck/unfavorable for coiling: Consider stent-assisted coiling before flow diversion
3. Flow diversion consideration: Reserve for cases where:
   • Coiling/stent-assisted coiling not feasible
   • Fusiform/dissecting morphology
   • Patient accepts 11-15% risk of ischemic complications
4. Avoid flow diversion if:
   • Ruptured saccular aneurysm amenable to coiling
   • Giant size (higher mortality)
   • Acute rupture setting (need dual antiplatelet therapy)

Critical Safety Considerations Across All Locations

Antiplatelet therapy requirement: Flow diverters necessitate dual antiplatelet therapy, creating hemorrhagic risk particularly with ventriculostomy placement in ruptured cases 1. This is why guidelines recommend avoiding stents/flow diverters in acute rupture when primary coiling is feasible.

Covered branch occlusion: Occurs in 5.5-10% of distal cases 3, 5, but symptomatic events are rare (1.1%) due to collateral circulation, particularly in ACA territory.

Perforator territory: Basilar apex location carries highest perforator infarction risk (7%) 7, a devastating complication given brainstem involvement.

Incomplete occlusion trajectory: Even with incomplete occlusion at early follow-up, many aneurysms continue progressing toward complete occlusion over time 10. However, this delayed occlusion pattern may be less acceptable for high-rupture-risk locations.

Comparative Context

Distal circulation aneurysms (pooled ACA/MCA/PCA data):

• Adequate occlusion: 90%, complete occlusion: 79% 5
• Good functional outcome: 97% 5
• Procedure-related morbidity: 1.5%, mortality: 0.6% 5
• Retreatment: 1.6% 5

These pooled results are heavily weighted toward ACA aneurysms (78.4% of cases) 5, which have more favorable anatomy and collateral circulation than MCA or basilar locations.

Evidence Quality Limitations

All studies are retrospective without randomized comparisons to clipping or coiling 3, 6, 8, 5, 7, 4. Selection bias is inherent—flow diverters are typically used for aneurysms deemed unfavorable for standard treatment. The 2023 AHA/ASA guidelines explicitly identify this as a knowledge gap, noting "insufficient data to provide definitive guidance, especially in the setting of emerging endovascular technologies" 1.

Practical Recommendations by Location

ACA (distal A2 and beyond): Flow diversion is reasonable for unruptured aneurysms, particularly when surgical access is challenging. High occlusion rates (89%) and excellent safety profile (97% good outcomes, 0% mortality) support this approach 3.

ACom: More technically challenging with lower occlusion rates (78%). Consider only when coiling/clipping pose high risk. Bifurcation anatomy and small vessel caliber increase technical difficulty 4.

MCA M1: Favor clipping for most cases, especially if ruptured. If flow diversion considered for unruptured aneurysms in poor surgical candidates, obtain preoperative MRI—wall enhancement predicts treatment failure 6. Accept that 25.9% will have postprocedural ischemia (mostly transient).

Basilar tip: Primary coiling remains preferred when feasible 2. Flow diversion should be reserved for complex cases (fusiform, wide-neck) where coiling fails or is not feasible, with full disclosure of 11-15% ischemic stroke risk and 7% perforator infarction risk 7. Recent data suggests improving outcomes but from single centers with high expertise 8.

Volume matters: The 2015 guidelines emphasize treatment at high-volume centers (>20 cases annually) 2. This is particularly critical for flow diversion in these challenging locations.